Brenner Robert
Chief Medical Officer
Brenner Robert has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Feb 25, 2026.
On the most recent filing, Brenner Robert is listed as Chief Medical Officer at Vera Therapeutics, Inc. Inside the rolling window, Brenner Robert reported no open-market purchases and 1 open-market sale totaling $90K in VERA.
Companies traded
Other insiders at VERA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$90K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brenner Robert made?
Brenner Robert has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Brenner Robert trade?
Brenner Robert has filed SEC Form 4 disclosures for 1 company, including VERA.
When was Brenner Robert's most recent SEC Form 4 filing?
Brenner Robert's most recent SEC Form 4 filing on Tracefour is dated Feb 25, 2026.
What is Brenner Robert's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brenner Robert is listed as Chief Medical Officer.
What is Brenner Robert's total buy and sell value in the current window?
Inside the rolling retention window, Brenner Robert bought $0 and sold $90K based on SEC Form 4 filings.
What was Brenner Robert's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,151 VERA shares on 2026-02-23, worth $90K, per SEC Form 4 filings.